Combating the symptoms of menopause
The good news is that women today can reasonably expect to live
into their 90s. The bad news is that women today can reasonably
expect to live to be in their 90s. Bad news, that is, without some
help along the way to deal with the stresses, strains, and realities
of growing older.
For women in their 40s and 50s, the onset of menopause can be a
troubling time. Many women go through it without a lot of problems.
For others, however, menopause can be an awful experience. Menopause
is that time in mid-life when hormone levels begin to decrease and
the menses cease. What sometimes accompanies this change are hot
flashes, night sweats, and mood swings. There is also the concern of
bone loss, caused in part by a lack of estrogen, one of the hormones
linked to the menstrual cycle.
Estrogen and progesterone have an active role in the menstrual
cycle. When their production is not in balance due to changes in the
ovaries and glands that produce the hormones, too much of one or the
other may be produced. What generally results is referred to as
estrogen dominance; that is, too much estrogen compared to
progesterone.
AIM RevitaFem® a natural, botanical supplement that, combined
with regular exercise, management of stress, a whole foods diet, and
elimination of toxins, combats the symptoms of menopause. AIM
RevitaFem® contains eight botanical ingredients, all contributing
unique properties to help control excess estrogen and assist in
regulating and balancing body systems. In general, a natural
ingredient in the product, called phytoestrogens, modulates and
helps regulate out-of-balance estrogen levels.
AIM RevitaFem® is a natural
alternative to hormone replacement therapy (HRT), which emerged in
the 1960s to treat the symptoms of menopause as well as a number of
other conditions including depression, cardiovascular disease, and
bone loss. While HRT was found to be effective, research has found a
number of health concerns that accompany it including blood clots,
stroke, coronary heart disease, and breast cancer. |